Rallybio Corporation
(RLYB)
undefined
undefined%
At close: undefined
1.12
1.35%
After-hours Dec 13, 2024, 06:32 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Net Income | -74.56M | -66.65M | -47.01M | -26.45M | -17.56M |
Depreciation & Amortization | 150.00K | 167.00K | 109.00K | 62.00K | 26.00K |
Stock-Based Compensation | 10.92M | 9.50M | 3.65M | 704.00K | 194.00K |
Other Working Capital | 4.38M | -1.42M | -2.80M | 1.40M | 1.34M |
Other Non-Cash Items | -1.05M | 640.00K | 1.50M | 1.52M | 144.00K |
Deferred Income Tax | - | - | - | - | 103.00K |
Change in Working Capital | 4.28M | -936.00K | -3.78M | 2.12M | 2.07M |
Operating Cash Flow | -60.27M | -57.28M | -45.53M | -22.04M | -15.03M |
Capital Expenditures | -12.00K | -54.00K | -333.00K | -137.00K | -188.00K |
Acquisitions | -2.25M | -300.00K | -2.00M | -1.94M | - |
Purchase of Investments | -110.66M | -201.32M | -2.00M | -1.94M | - |
Sales Maturities Of Investments | 138.33M | 89.50M | 2.00M | 1.94M | - |
Other Investing Acitivies | 2.25M | -112.12K | -2.00K | -1.94K | - |
Investing Cash Flow | 27.66M | -112.17M | -2.33M | -2.07M | -188.00K |
Debt Repayment | - | - | - | - | - |
Common Stock Repurchased | 282.00K | - | - | - | - |
Dividend Paid | - | - | - | - | - |
Other Financial Acitivies | 143.00K | -455.00K | -3.23M | -319.00K | -33.00K |
Financial Cash Flow | 143.00K | 51.08M | 82.97M | 144.89M | 31.57M |
Net Cash Flow | -32.46M | -118.38M | 35.10M | 120.78M | 16.35M |
Free Cash Flow | -60.28M | -57.34M | -45.87M | -22.18M | -15.21M |